{"resourceType":"ValueSet","id":"valueset-labelerBusinessOperations","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C25391</td><td>ANALYSIS</td></tr><tr><td>C101509</td><td>API/FDF ANALYTICAL TESTING</td></tr><tr><td>C82401</td><td>API MANUFACTURE</td></tr><tr><td>C101511</td><td>CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY</td></tr><tr><td>C73608</td><td>DISTRIBUTES DRUG PRODUCTS UNDER OWN PRIVATE LABEL</td></tr><tr><td>C101510</td><td>FDF MANUFACTURE</td></tr><tr><td>C112113</td><td>HUMAN DRUG COMPOUNDING OUTSOURCING FACILITY</td></tr><tr><td>C101512</td><td>IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING</td></tr><tr><td>C84732</td><td>LABEL</td></tr><tr><td>C43360</td><td>MANUFACTURE</td></tr><tr><td>C84635</td><td>MEDICATED ANIMAL FEED MANUFACTURE</td></tr><tr><td>C122061</td><td>OUTSOURCING ANIMAL DRUG COMPOUNDING</td></tr><tr><td>C84731</td><td>PACK</td></tr><tr><td>C84386</td><td>PARTICLE SIZE REDUCTION</td></tr><tr><td>C91403</td><td>POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION</td></tr><tr><td>C73607</td><td>RELABEL</td></tr><tr><td>C73606</td><td>REPACK</td></tr><tr><td>C70827</td><td>SALVAGE</td></tr><tr><td>C175317</td><td>SIP FOREIGN SELLER</td></tr><tr><td>C118412</td><td>THIRD-PARTY LOGISTICS PROVIDER</td></tr><tr><td>C125710</td><td>TRANSFILL</td></tr><tr><td>C118411</td><td>WHOLESALE DRUG DISTRIBUTOR</td></tr></table></li></ul></div>"},"url":"http://hl7.org/fhir/us/spl/ValueSet/valueset-labelerBusinessOperations","version":"0.1.0","name":"LabelerBusinessOperations","status":"active","date":"2021-07-06T09:10:48-06:00","publisher":"Biomedical Research and Regulatory WG","contact":[{"name":"Biomedical Research and Regulatory WG","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/rcrim/index.cfm"}]}],"description":"The set of business operations that can be specified for a labelling facility.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US","display":"United States of America"}]}],"compose":{"include":[{"system":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl","concept":[{"code":"C25391","display":"ANALYSIS"},{"code":"C101509","display":"API/FDF ANALYTICAL TESTING"},{"code":"C82401","display":"API MANUFACTURE"},{"code":"C101511","display":"CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY"},{"code":"C73608","display":"DISTRIBUTES DRUG PRODUCTS UNDER OWN PRIVATE LABEL"},{"code":"C101510","display":"FDF MANUFACTURE"},{"code":"C112113","display":"HUMAN DRUG COMPOUNDING OUTSOURCING FACILITY"},{"code":"C101512","display":"IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING"},{"code":"C84732","display":"LABEL"},{"code":"C43360","display":"MANUFACTURE"},{"code":"C84635","display":"MEDICATED ANIMAL FEED MANUFACTURE"},{"code":"C122061","display":"OUTSOURCING ANIMAL DRUG COMPOUNDING"},{"code":"C84731","display":"PACK"},{"code":"C84386","display":"PARTICLE SIZE REDUCTION"},{"code":"C91403","display":"POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION"},{"code":"C73607","display":"RELABEL"},{"code":"C73606","display":"REPACK"},{"code":"C70827","display":"SALVAGE"},{"code":"C175317","display":"SIP FOREIGN SELLER"},{"code":"C118412","display":"THIRD-PARTY LOGISTICS PROVIDER"},{"code":"C125710","display":"TRANSFILL"},{"code":"C118411","display":"WHOLESALE DRUG DISTRIBUTOR"}]}]}}